268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading

First, we discuss why Wall Street was less than convinced by Biogen's attempt to assuage concerns about its credibility. Then we explain an insider trading scandal that bridges biotech and elite-level soccer, the latest concerns over Wegovy, and the rest of the week's news in the life sciences. We also break some bittersweet news, with the help of some headline names from around biotech.

Episode metadata supplied by the publisher feed · Published Jul 27, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading

0:00 36:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 36 minutes long.

When was this The Readout Loud episode published?

This episode was published on July 27, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!